Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary-Ann Bjornsti

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Cancer Cell|October 26, 2002
Cancer therapeutics in yeastMary Ann Bjornsti
F1000Research|October 12, 2019
Topoisomerases and cancer chemotherapy: recent advances and unanswered questionsMary-Ann Bjornsti, Scott H Kaufmann
Cancer Cell|June 15, 2004
Lost in translation: dysregulation of cap-dependent translation and cancerMary-Ann Bjornsti, Peter J Houghton
Expert Opinion on Therapeutic Targets|August 21, 2025
Rhabdomyosarcoma: development of molecular therapeutics under the microscopePeter J Houghton, Mary-Ann Bjornsti
The Journal of Biological Chemistry|December 7, 2007
Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecinMarié van der Merwe, Mary-Ann Bjornsti
Cancer Biology & Therapy|July 25, 2003
Rapamycins: mechanism of action and cellular resistanceShile Huang, Mary-Ann Bjornsti, Peter J Houghton
Cancer Chemotherapy and Pharmacology|May 22, 2017
DNA topoisomerase-targeting chemotherapeutics: what's new?Selma M Cuya, Mary-Ann Bjornsti, Robert C A M van Waardenburg
The Journal of Biological Chemistry|February 6, 2007
Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethalityCarmen Losasso, Erica Cretaio, Komaraiah Palle, et al.
Cell|August 21, 2010
Cellular strategies for regulating DNA supercoiling: a single-molecule perspectiveDaniel A Koster, Aurélien Crut, Stewart Shuman, et al.
DNA Repair|May 23, 2006
Trapping of DNA topoisomerase I on nick-containing DNA in cell free extracts of Saccharomyces cerevisiaeNatalia Lebedeva, Patricia Auffret Vander Kemp, Mary-Ann Bjornsti, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cancer Cell|October 26, 2002
Cancer therapeutics in yeastMary Ann Bjornsti
F1000Research|October 12, 2019
Topoisomerases and cancer chemotherapy: recent advances and unanswered questionsMary-Ann Bjornsti, Scott H Kaufmann
Cancer Cell|June 15, 2004
Lost in translation: dysregulation of cap-dependent translation and cancerMary-Ann Bjornsti, Peter J Houghton
Expert Opinion on Therapeutic Targets|August 21, 2025
Rhabdomyosarcoma: development of molecular therapeutics under the microscopePeter J Houghton, Mary-Ann Bjornsti
The Journal of Biological Chemistry|December 7, 2007
Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecinMarié van der Merwe, Mary-Ann Bjornsti
Cancer Biology & Therapy|July 25, 2003
Rapamycins: mechanism of action and cellular resistanceShile Huang, Mary-Ann Bjornsti, Peter J Houghton
Cancer Chemotherapy and Pharmacology|May 22, 2017
DNA topoisomerase-targeting chemotherapeutics: what's new?Selma M Cuya, Mary-Ann Bjornsti, Robert C A M van Waardenburg
The Journal of Biological Chemistry|February 6, 2007
Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethalityCarmen Losasso, Erica Cretaio, Komaraiah Palle, et al.
Cell|August 21, 2010
Cellular strategies for regulating DNA supercoiling: a single-molecule perspectiveDaniel A Koster, Aurélien Crut, Stewart Shuman, et al.
DNA Repair|May 23, 2006
Trapping of DNA topoisomerase I on nick-containing DNA in cell free extracts of Saccharomyces cerevisiaeNatalia Lebedeva, Patricia Auffret Vander Kemp, Mary-Ann Bjornsti, et al.
Pageof 4